1. Home
  2. KE vs DAWN Comparison

KE vs DAWN Comparison

Compare KE & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$28.98

Market Cap

738.4M

Sector

Technology

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$9.60

Market Cap

624.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
DAWN
Founded
1961
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.4M
624.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KE
DAWN
Price
$28.98
$9.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$28.00
$26.56
AVG Volume (30 Days)
155.4K
3.0M
Earning Date
02-03-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
91.88
N/A
EPS
0.96
N/A
Revenue
$1,478,074,000.00
$133,672,000.00
Revenue This Year
N/A
$15.51
Revenue Next Year
$4.71
$49.99
P/E Ratio
$30.29
N/A
Revenue Growth
N/A
31.11
52 Week Low
$12.41
$5.64
52 Week High
$33.19
$13.53

Technical Indicators

Market Signals
Indicator
KE
DAWN
Relative Strength Index (RSI) 49.38 59.11
Support Level $28.36 $8.13
Resistance Level $31.45 $10.47
Average True Range (ATR) 1.01 0.62
MACD -0.13 0.11
Stochastic Oscillator 26.49 66.15

Price Performance

Historical Comparison
KE
DAWN

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: